Empagliflozin reduces Ca/calmodulin-dependent kinase II activity in isolated ventricular cardiomyocytes.
Mustroph J, Wagemann O, Lücht CM, Trum M, Hammer KP, Sag CM, Lebek S, Tarnowski D, Reinders J, Perbellini F, Terracciano C, Schmid C, Schopka S, Hilker M, Zausig Y, Pabel S, Sossalla ST, Schweda F, Maier LS, Wagner S.
Mustroph J, et al.
ESC Heart Fail. 2018 Aug;5(4):642-648. doi: 10.1002/ehf2.12336.
ESC Heart Fail. 2018.
PMID: 30117720
Free PMC article.